Clinical Trial Update: A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing immunotherapy with chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Carcinoma

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN